Use of the Thrombectomy Device ReVive™ SE in the Acute Treatment of Stroke "REVIVE SE"

Not yet recruiting

Phase N/A Results N/A

Eligibility Criteria

Inclusion Criteria

- Patient with an ischemic stroke detected by Computed Tomography (CT) or Magnetic Resonance Image (MRI)
- Large proximal arterial occlusion : M1 segment of the Middle cerebral artery (MCA), Internal Carotid Artery (ICA) or Basilar Artery (BA)
- Last known well (without neurological symptoms) ≤ 8 hours of treatment initiation
- Score NIHSS ≥4
- Eligibility on an endovascular procedure using REVIVETM SE device
- No opposition of the patient to participate at the study

Exclusion Criteria

- Diagnostic cerebral imaging impossible
- Distal occlusion
- Tortuous vessel or other specificity preventing the access of device
- Vessel diameter < 1.5 mm
- Known hypersensibility or allergy to nitinol
- Subjects not covered by or having the right to social security
- Deprivation of civil rights (guardianship, safeguard justice)